Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ostapowicz

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of the American Chemical Society|January 31, 2013
Bifunctional ruthenium(II) hydride complexes with pendant strong Lewis acid moieties: structure, dynamics, and cooperativityThomas G Ostapowicz, Carina Merkens, Markus Hölscher, et al.
Hepatology (Baltimore, Md.)|June 10, 1998
Role of alcohol in the progression of liver disease caused by hepatitis C virus infectionG Ostapowicz, K J Watson, S A Locarnini, et al.
Angewandte Chemie (International Ed. in English)|September 17, 2013
Carbon dioxide as a C₁ building block for the formation of carboxylic acids by formal catalytic hydrocarboxylationThomas G Ostapowicz, Marc Schmitz, Monika Krystof, et al.
Dalton Transactions (Cambridge, England : 2003)|August 19, 2016
Synthesis of a sterically bulky diphosphine synthon and Ru(ii) complexes of a cooperative tridentate enamide-diphosphine ligand platformVincent T Annibale, Thomas G Ostapowicz, Stefan Westhues, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2004
Correlation of percutaneous liver biopsy fragmentation with the degree of fibrosisA H Malik, K S Kumar, P F Malet, et al.
Hepatology (Baltimore, Md.)|April 3, 2001
Hepatitis B infection in patients with acute liver failure in the United StatesE K Teo, G Ostapowicz, M Hussain, et al.
Internal Medicine Journal|August 2, 2001
Changes in hepatitis C-related liver disease in a large clinic populationG Ostapowicz, M Dallinger, S J Bell, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
A randomized trial of high-dose interferon alpha-2b, with or without ribavirin, in chronic hepatitis C patients who have not responded to standard dose interferonA H Malik, K S Kumar, P F Malet, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of the American Chemical Society|January 31, 2013
Bifunctional ruthenium(II) hydride complexes with pendant strong Lewis acid moieties: structure, dynamics, and cooperativityThomas G Ostapowicz, Carina Merkens, Markus Hölscher, et al.
Hepatology (Baltimore, Md.)|June 10, 1998
Role of alcohol in the progression of liver disease caused by hepatitis C virus infectionG Ostapowicz, K J Watson, S A Locarnini, et al.
Angewandte Chemie (International Ed. in English)|September 17, 2013
Carbon dioxide as a C₁ building block for the formation of carboxylic acids by formal catalytic hydrocarboxylationThomas G Ostapowicz, Marc Schmitz, Monika Krystof, et al.
Dalton Transactions (Cambridge, England : 2003)|August 19, 2016
Synthesis of a sterically bulky diphosphine synthon and Ru(ii) complexes of a cooperative tridentate enamide-diphosphine ligand platformVincent T Annibale, Thomas G Ostapowicz, Stefan Westhues, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2004
Correlation of percutaneous liver biopsy fragmentation with the degree of fibrosisA H Malik, K S Kumar, P F Malet, et al.
Hepatology (Baltimore, Md.)|April 3, 2001
Hepatitis B infection in patients with acute liver failure in the United StatesE K Teo, G Ostapowicz, M Hussain, et al.
Internal Medicine Journal|August 2, 2001
Changes in hepatitis C-related liver disease in a large clinic populationG Ostapowicz, M Dallinger, S J Bell, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
A randomized trial of high-dose interferon alpha-2b, with or without ribavirin, in chronic hepatitis C patients who have not responded to standard dose interferonA H Malik, K S Kumar, P F Malet, et al.
Pageof 2